Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University

About this trial

Through the use of community-engaged processes, this project seeks to develop and implement clinical decision support (CDS) and a kidney health coaching (KHC) intervention. The CDS seeks to streamline workflows to effectively screen, identify, and link to care for those patients with advanced chronic kidney disease (CKD).

The overall project goals are to 1.) Design and conduct community-engaged clinical trials to test new interventions that dismantle the systemic factors that contribute to kidney health disparities. 2.) Foster research collaborations between investigators, people living with kidney disease, community-based organizations, and other key stakeholders.

Researchers aim to assess whether the KHC intervention is effective at delaying the transition to kidney replacement therapy (KRT) and central venous catheter use or death.

Eligibility criteria

Qualifiers

Identifies as African American or Black

Two estimated glomerular filtration rates (eGFRs) < 29 separated by at least 90 days but within the past 2 years, or a Kidney Failure Risk Equation (KFRE) score of 10% or greater likelihood of kidney failure within the next 2 years

Had an encounter at Emory Healthcare through an ambulatory visit or inpatient stay (i.e., ER or hospital visit within the previous 2 months

Stated willingness to comply with all study procedures and availability for the duration of the study

Disqualifiers

Currently on dialysis

currently receiving hospice care or other types of conservative management for terminal illness

Currently on waitlist, or referred for/or completed a transplant evaluation visit within the past 2 years

Kidney or another solid organ transplant

Trial design

Treatments tested in this trial

  • Kidney Health Coaching
  • Usual Care

Treatment groups

600 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Emory University

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

James T. Laney School of Graduate Studies

Collaborator